We comply with the
HONcode standard for trustworthy health information:
verify here

The European LeukemiaNet is an EU-funded organisation of physicians, scientists and patients with interest in leukemia. It aims to improve the treatment and knowledge about Leukemia in Europe and spread excellence. The website delivers information for physicians, patients (e.g. patient organisations in Europe), ongoing clinical trials and further information about the disease. You can get information about the European LeukemiaNet in various european languages. The European LeukemiaNet is funded by the 6th Framework Program of the European Community.

News

European LeukemiaNet - Developing stratified diagnostic and treatment approaches

The most visible results of the ELN are the guidelines and managment recommendations for virtually every leukemia and interdisciplinary speciality which have lain the groundwork for uniform definitions and standards required for common clinical trials and projects.

Survey: Social Networks

The European LeukemiaNet is interested to be up to date and to match the website content and its functions to the ELN members’ needs. As social networks are on everyone’s lips these days we wondered if this issue is also of interest for our users.

ELN recommendations

CML management recommendations (Baccarani et al., J Clin Oncol 2009;27:6041-51) among the 50 top cited papers of JCO 2009.

Japanese ELN recommendations for CML

The ELN recommendations for CML are now available in Japanese language. The booklet can be ordered directly from ELIC.

ELN Frontiers Meeting 2011: Abstracts available online

ELN Frontiers is an annual educational program of the EUTOS (European Treatment and Outcome Study for CML) project, a collaboration between the European LeukemiaNet and Novartis Oncology Europe. Abstracts of the meeting in Berlin are available online now.

Events
Mo 2012/05/21 - Tu 2012/05/22 Naples Fellows Days An educational day for European fellows on behalf of EUTOS for CML
Sa 2012/06/09 - Su 2012/06/10 DLH Patient Congress
Th 2012/06/14 - Su 2012/06/17 EHA 2012: 17th Congress of the EHA
Sa 2012/06/16 - We 2012/06/20 XIX. Wilsede-Meeting Normal Stem Cells, Ageing, and Cancer Immunotherapy and Surveillance Clinical Gene Therapy Epigenetics and Reprogramm···
Fr 2012/06/29 - Sa 2012/06/30 CML Study Group Meeting / 21st International CML-Workshop

The European LeukemiaNet

189 Participating Centers in 38 Countries (1000 Researchers and Associates) are cooperating in the European Leukemia Net. The objective is to integrate the 108 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their 105 interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia related research and health care (data updated March 2012).

Keywords: leukemia, leukaemia, leukämie, leucemie, leucémie, leucemia, leukemi, leukemie, lösemi, Лейкоз, λευχαιμία, سرطان الدّم, 白血病, leukemija, leukemije, leŭkemio, biaŁacka,ש"עסרטן הדם, לויקמיה